Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc. Income Statement

Revenue, expenses, and profitability over time
Market Cap$48.1M

No metrics found for this filter.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.